Abbott Laboratories
NYSE-ABT
Company Overview
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Name
Abbott Laboratories
CEO
Mr. Robert B. Ford
Website
www.abbott.com
Sector
Health Care Equipment and Supplies
Year Founded
1888
Profile
Market Cap
$198.61B
EV
$206.48B
Shares Out
1,739.9M
Revenue
$40.73B
Employees
114,000
Margins
Gross
55.47%
EBITDA
25.96%
Operating
17.98%
Pre-Tax
15.98%
Net
13.65%
FCF
13.88%
Returns (5Yr Avg)
ROA
7.77%
ROTA
27.48%
ROE
16.22%
ROCE
12.17%
ROIC
11.46%
Valuation (TTM)
P/E
—
P/B
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
EV/Gross Profit
—
Valuation (NTM)
Price Target
$124.12
P/E
—
PEG
—
EV/Sales
—
EV/EBITDA
—
P/FCF
—
Financial Health
Cash
$7,219M
Net Debt
$7,626M
Debt/Equity
0.38
EBIT/Interest
12.09
Growth (CAGR)
Rev 3Yr
0.41%
Rev 5Yr
5.65%
Rev 10Yr
7.56%
Dil EPS 3Yr
-3.7%
Dil EPS 5Yr
14.28%
Dil EPS 10Yr
7.47%
Rev Fwd 2Yr
5.65%
EBITDA Fwd 2Yr
6.87%
EPS Fwd 2Yr
7.59%
EPS LT Growth Est
8.45%
Dividends
Yield
—
Payout
67.91%
DPS
$2.16
DPS Growth 3Yr
8.1%
DPS Growth 5Yr
11.74%
DPS Growth 10Yr
10.44%
DPS Growth Fwd 2Yr
7.17%